171. Wilson disease Clinical trials / Disease details

Clinical trials : 79 / Drugs : 77 - (DrugBank : 17) / Drug target genes : 6 - Drug target pathways : 30

3 trials found

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT05305872 (ClinicalTrials.gov)	January 1, 2023	24/11/2021	Gandouling in the Treatment of Wilson's Disease	The First Affiliated Hospital of Anhui University of Traditional Chinese Medicine	Wilson's Disease	Drug: Gandouling	Jun Li	NULL	Not yet recruiting	15 Years	85 Years	All	216	Phase 4	NULL
2	ITMCTR2100005333	2021-12-12	2021-11-26	A multicenter, randomized controlled, double-blind and double simulated clinical evaluation of gandouling tablet in the treatment of Wilson's disease	A multicenter, randomized controlled, double-blind and double simulated clinical evaluation of gandouling tablet in the treatment of patients with hepatolenticular degeneration	Wilson's diasease	2:Zinc gluconate;1:Gandouling;	The First Affiliated Hospital of Anhui University of traditional Chinese Medicine	NULL	Pending	15	85	Both	2:100;1:100;	Phase 1	China
3	ChiCTR2100053629	2021-12-12	2021-11-26	A multicenter, randomized controlled, double-blind and double simulated clinical evaluation of gandouling tablet in the treatment of Wilson's disease	A multicenter, randomized controlled, double-blind and double simulated clinical evaluation of gandouling tablet in the treatment of patients with hepatolenticular degeneration	Wilson's disease	A group:Gandouling tablet + zinc gluconate simulator;B group:Zinc gluconate + gandouling tablet simulator;	The First Affiliated Hospital of Anhui University of Traditional Chinese Medicine	NULL	Pending	15		Both	A group:100;B group:100;		China